Literature DB >> 33450982

Nutritional Therapy Strategies in Pediatric Crohn's Disease.

Charlotte M Verburgt1,2, Mohammed Ghiboub1,2, Marc A Benninga1, Wouter J de Jonge2,3, Johan E Van Limbergen1,2,4.   

Abstract

The increase in incidences of pediatric Crohn's Disease (CD) worldwide has been strongly linked with dietary shifts towards a Westernized diet, ultimately leading to altered gut microbiota and disturbance in intestinal immunity and the metabolome. Multiple clinical studies in children with CD have demonstrated the high efficacy of nutritional therapy with exclusive enteral nutrition (EEN) to induce remission with an excellent safety profile. However, EEN is poorly tolerated, limiting its compliance and clinical application. This has spiked an interest in the development of alternative and better-tolerated nutritional therapy strategies. Several nutritional therapies have now been designed not only to treat the nutritional deficiencies seen in children with active CD but also to correct dysbiosis and reduce intestinal inflammation. In this review, we report the most recent insights regarding nutritional strategies in children with active CD: EEN, partial enteral nutrition (PEN), Crohn's disease exclusive diet (CDED), and CD treatment-with-eating diet (CD-TREAT). We describe their setup, efficacy, safety, and (dis)advantages as well as some of their potential mechanisms of action and perspectives. A better understanding of different nutritional therapeutic options and their mechanisms will yield better and safer management strategies for children with CD and may address the barriers and limitations of current strategies in children.

Entities:  

Keywords:  diet; inflammation; microbiota; nutritional therapy; pediatric Crohn’s disease

Year:  2021        PMID: 33450982      PMCID: PMC7828385          DOI: 10.3390/nu13010212

Source DB:  PubMed          Journal:  Nutrients        ISSN: 2072-6643            Impact factor:   5.717


  146 in total

1.  The major pathway by which polymeric formula reduces inflammation in intestinal epithelial cells: a microarray-based analysis.

Authors:  Lily Nahidi; Susan M Corley; Marc R Wilkins; Jerry Wei; Moftah Alhagamhmad; Andrew S Day; Daniel A Lemberg; Steven T Leach
Journal:  Genes Nutr       Date:  2015-07-17       Impact factor: 5.523

2.  Comparative Effectiveness of Nutritional and Biological Therapy in North American Children with Active Crohn's Disease.

Authors:  Dale Lee; Robert N Baldassano; Anthony R Otley; Lindsey Albenberg; Anne M Griffiths; Charlene Compher; Eric Z Chen; Hongzhe Li; Erin Gilroy; Lisa Nessel; Amy Grant; Christel Chehoud; Frederic D Bushman; Gary D Wu; James D Lewis
Journal:  Inflamm Bowel Dis       Date:  2015-08       Impact factor: 5.325

3.  The effect of polymeric formula on enterocyte differentiation.

Authors:  Gabrielle R Budd; Alan Aitchison; Andrew S Day; Jacqueline I Keenan
Journal:  Innate Immun       Date:  2017-01-19       Impact factor: 2.680

4.  Animal protein intake and risk of inflammatory bowel disease: The E3N prospective study.

Authors:  Prévost Jantchou; Sophie Morois; Françoise Clavel-Chapelon; Marie-Christine Boutron-Ruault; Franck Carbonnel
Journal:  Am J Gastroenterol       Date:  2010-05-11       Impact factor: 10.864

5.  Elemental versus polymeric enteral nutrition in paediatric Crohn's disease: a multicentre randomized controlled trial.

Authors:  J F Ludvigsson; M Krantz; L Bodin; L Stenhammar; B Lindquist
Journal:  Acta Paediatr       Date:  2004-03       Impact factor: 2.299

6.  Definition of phenotypic characteristics of childhood-onset inflammatory bowel disease.

Authors:  Johan Van Limbergen; Richard K Russell; Hazel E Drummond; Marian C Aldhous; Nicola K Round; Elaine R Nimmo; Linda Smith; Peter M Gillett; Paraic McGrogan; Lawrence T Weaver; W Michael Bisset; Gamal Mahdi; Ian D Arnott; Jack Satsangi; David C Wilson
Journal:  Gastroenterology       Date:  2008-07-03       Impact factor: 22.682

7.  The Medical Management of Paediatric Crohn's Disease: an ECCO-ESPGHAN Guideline Update.

Authors:  Patrick F van Rheenen; Marina Aloi; Amit Assa; Jiri Bronsky; Johanna C Escher; Ulrika L Fagerberg; Marco Gasparetto; Konstantinos Gerasimidis; Anne Griffiths; Paul Henderson; Sibylle Koletzko; Kaija-Leena Kolho; Arie Levine; Johan van Limbergen; Francisco Javier Martin de Carpi; Víctor Manuel Navas-López; Salvatore Oliva; Lissy de Ridder; Richard K Russell; Dror Shouval; Antonino Spinelli; Dan Turner; David Wilson; Eytan Wine; Frank M Ruemmele
Journal:  J Crohns Colitis       Date:  2020-10-07       Impact factor: 10.020

Review 8.  The Impact of Western Diet and Nutrients on the Microbiota and Immune Response at Mucosal Interfaces.

Authors:  Donjete Statovci; Mònica Aguilera; John MacSharry; Silvia Melgar
Journal:  Front Immunol       Date:  2017-07-28       Impact factor: 7.561

Review 9.  Paediatric inflammatory bowel disease: a mechanistic approach to investigate exclusive enteral nutrition treatment.

Authors:  Lily Nahidi; Andrew S Day; Daniel A Lemberg; Steven T Leach
Journal:  Scientifica (Cairo)       Date:  2014-05-21

10.  Ranking microbiome variance in inflammatory bowel disease: a large longitudinal intercontinental study.

Authors:  Adam G Clooney; Julia Eckenberger; Emilio Laserna-Mendieta; Kathryn A Sexton; Matthew T Bernstein; Kathy Vagianos; Michael Sargent; Feargal J Ryan; Carthage Moran; Donal Sheehan; Roy D Sleator; Laura E Targownik; Charles N Bernstein; Fergus Shanahan; Marcus J Claesson
Journal:  Gut       Date:  2020-06-14       Impact factor: 23.059

View more
  2 in total

Review 1.  Nutritional Therapies and Their Influence on the Intestinal Microbiome in Pediatric Inflammatory Bowel Disease.

Authors:  Lara Hart; Charlotte M Verburgt; Eytan Wine; Mary Zachos; Alisha Poppen; Mallory Chavannes; Johan Van Limbergen; Nikhil Pai
Journal:  Nutrients       Date:  2021-12-21       Impact factor: 5.717

2.  Exclusive enteral nutrition remodels the intestinal flora in patients with active Crohn's disease.

Authors:  Jingjing Jiang; Lu Chen; Yanfang Chen; Hong Chen
Journal:  BMC Gastroenterol       Date:  2022-04-30       Impact factor: 3.067

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.